Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 1/20 | 0.64 |
| ▸ | SHBG | P04278 | 1/20 | 0.47 |
| ▸ | BACE1 | P56817 | 1/20 | 0.46 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.44 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.44 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | ESR1 | P03372 | 2/20 | 0.44 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.44 |
| ▸ | DBH | P09172 | 1/20 | 0.44 |
| ▸ | MGLL | Q99685 | 1/20 | 0.42 |
| ▸ | CNR1 | P21554 | 1/20 | 0.42 |
| ▸ | CNR2 | P34972 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23250680 | 0.84 | TRPA1 (0.55) | TRPA1BACE1POLBKDM4EALDH1A1 | |
| SCHEMBL1524010 | 0.83 | CNR1 (0.64) | SHBGBACE1CYP3A4CNR1CNR2 | |
| SCHEMBL241420 | 0.82 | TRPA1 (0.64) | TRPA1BACE1 | |
| SCHEMBL30058625 | 0.81 | CA1 (0.61) | SHBGCYP17A1CYP3A4CYP19A1CYP11B1 | |
| SCHEMBL1338001 | 0.81 | KDM4E (0.52) | BACE1CYP17A1CYP3A4CYP19A1CYP11B1 | |
| SCHEMBL545298 | 0.81 | CA1 (0.61) | SHBGCYP17A1CYP3A4CYP19A1CYP11B1 | |
| SCHEMBL8443334 | 0.79 | NPC1 (0.55) | SHBGBACE1CYP3A4ESR1CNR1 | |
| SCHEMBL1390780 | 0.79 | CYP17A1 (0.46) | SHBGBACE1CYP17A1CYP3A4CYP19A1 | |
| SCHEMBL30683156 | 0.79 | CYP17A1 (0.46) | SHBGBACE1CYP17A1CYP3A4CYP19A1 | |
| SCHEMBL6890833 | 0.79 | CYP17A1 (0.46) | SHBGCYP17A1CYP3A4CYP19A1CYP11B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 136 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113396137-A | Method for producing 1,1, 1-trifluoro-2, 2-bisarylethane, and 1,1, 1-trifluoro-2, 2-bisarylethane | 中央硝子株式会社 | 2021-09-14 | — | — | CN | claimed |
| CN-101624442-A | Polycarbonate resin and electrophotographic photoreceptor using the same | IDEMITSU KOSAN CO | 2010-01-13 | — | — | CN | claimed |
| CN-1894818-A | Fuel for fuel cell, fuel cell and use thereof | KURITA WATER IND LTD (JP) | 2007-01-10 | — | — | CN | claimed |
| CN-1659174-A | Hydrogen storage method, hydrogen clathrate and process for producing the same | KURITA WATER IND LTD (JP) | 2005-08-24 | — | — | CN | claimed |
| US-20240228770-A1 | RESIN PARTICLES, METHOD FOR PRODUCING RESIN PARTICLES, TONER, DEVELOPER, TONER STORAGE, AND IMAGE FORMING APPARATUS | RICOH COMPANY, LTD. (JP) | 2024-07-11 | — | — | US | disclosed |
| CN-115190894-B | Curable resin, curable resin composition, cured product, electronic device, laminate material, electronic component sealing material, and method for producing curable resin | 中央硝子株式会社 | 2024-06-21 | — | — | CN | disclosed |
| CN-116736653-A | Electrophotographic photoreceptor, process cartridge, and image forming apparatus | 富士胶片商业创新有限公司 | 2023-09-12 | — | — | CN | disclosed |
| WO-2023091578-A1 | LIQUID MOLD COMPOUNDS, REACTION PRODUCTS OF WHICH BECOME PLATABLE UPON EXPOSURE TO LASER ENERGY | HENKEL AG & CO. KGAA (DE) | 2023-05-25 | — | — | WO | disclosed |
| US-20230038124-A1 | NOVEL SUBSTITUTED CONDENSED RING COMPOUND | Sumitomo Pharma Co., Ltd. (JP) | 2023-02-09 | — | — | US | disclosed |
| WO-2022253101-A1 | PYRIDAZINONE COMPOUND AS PARP7 INHIBITOR | 上海优理惠生医药有限公司 | 2022-12-08 | — | — | WO | disclosed |
| WO-2022246086-A1 | ANTIBODY DRUG CONJUGATES USING MATES TECHNOLOGY FOR DELIVERING CYTOTOXIC AGENTS | BIOHAVEN THERAPEUTICS LTD. (US) | 2022-11-24 | — | — | WO | disclosed |
| CN-115190894-A | Curable resin, curable resin composition, cured product, electronic device, laminate material, electronic component sealing material, and method for producing curable resin | 中央硝子株式会社 | 2022-10-14 | — | — | CN | disclosed |
| EP-1361241-A1 | Process for producing raw polycarbonate resin material and producing polycarbonate resin | IDEMITSU PETROCHEMICAL CO., LTD. (JP) | 2003-11-12 | — | — | EP | disclosed |
| WO-2003068235-A1 | NICOTINAMIDE DERIVATIVES USEFUL AS PDE4 INHIBITORS | PFIZER LIMITED (GB) | 2003-08-21 | — | — | WO | disclosed |
| CN-1364176-A | Processes for producing raw polycarbonate resin material and producing polycarbonate resin | IDEMITSU PETROCHEMICAL CO (JP) | 2002-08-14 | — | — | CN | disclosed |
| EP-0709358-B1 | NOVEL CLATHRATE COMPOUND, PROCESS FOR PRODUCING THE SAME, AND ANTIFOULING AGENT | NIPPON SODA CO (JP) | 1999-10-13 | — | — | EP | disclosed |
| EP-0816349-A1 | NOVEL CLATHRATE COMPOUND, PROCESS FOR PRODUCING THE SAME, AND COATING COMPOSITION CONTAINING SAID NOVEL CLATHRATE COMPOUND | ROHM AND HAAS COMPANY (US) | 1998-01-07 | — | — | EP | disclosed |
| EP-0709358-A1 | NOVEL CLATHRATE COMPOUND, PROCESS FOR PRODUCING THE SAME, AND ANTIFOULING AGENT | NIPPON SODA CO., LTD. (JP) | 1996-05-01 | — | — | EP | disclosed |
| US-5389444-A | Polycarbonate containing styrylamine repeating unit and emitter, and hole injecting material | IDEMITSU KOSAN CO., LTD. (JP) | 1995-02-14 | — | — | US | disclosed |
| EP-0557534-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1993-09-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230038124-A1 | NOVEL SUBSTITUTED CONDENSED RING COMPOUND | CYP51A1, HDAC11, MMP9 | TRPA1 3670/4885SHBG 3382/4885BACE1 10/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.